Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN90948816Phase 3Completed
Phase 3 trial of eucalyptol in asthma (2 arms), sponsored by MKL Institute of Clinical Research. Primary endpoint: Composite scores of lung function parameters, asthma symptoms and quality of life. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN90948816.